Memphis-based SweetBio starts 2023 in a big way
The start-up sold all of its initial offering of 1,000 units. Plans are to have the capacity to make a million units of its product. by the end of 2023.
SweetBio, a graduate of the “ZeroTo510” accelerator in Memphis and Launch Tennessee’s “The TENN” master accelerator program, has started 2023 in a big way.
According to a recent article in Memphis Inno, the company took its bioengineered wound care product to market and swiftly sold all 1,000 units in its inventory. Now, Sweet Bio is focused on raising funds to make more, with the goal of bringing the amount it can manufacture from hundreds to thousands in the next six months.
By the end of 2023, the start-up hopes to have the capacity to make a million units of its product.
“We have already received exponential demand from our first order,” said Kayla Rodriguez Graff, SweetBio’s Co-Founder and Chief Executive Officer. “And we need to manufacture more products.”
Graff and two other individuals founded the start-up in 2015 after about three years of in vitro development. Its signature product is named Apis and draws on the legendary healing powers of Manuka honey along with collagen. Many of the patients who use it have diabetic ulcers, venous ulcers, bedsores, and lesions at surgical sites, and studies show that the product has both helped close wounds and prevent amputations.
